Latest Prasugrel Stories

2009-03-24 07:00:00

Growth Will be Driven by Drugs from Eli Lilly/Daiichi Sankyo, AstraZeneca, and Schering-Plough, According to a New Report from Decision Resources WALTHAM, Mass., March 24 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, despite the patent expiries by 2012 of the two sales-leading therapies, new product launches will drive an increase of $4.6 billion in the overall coronary heart disease market by...

2009-03-12 17:30:00

A Phase II Study Published in The Lancet of Fast-Tracked Antiplatelet Agent Showed No Increase in TIMI Major and Minor Bleeding and was Well Tolerated When Given With Standard Platelet Therapy KENILWORTH, N.J., March 12 /PRNewswire-FirstCall/ -- Results of a Schering-Plough Corporation (NYSE: SGP) Phase II trial of SCH 530348, a novel oral thrombin receptor antagonist (TRA), were published today in The Lancet and demonstrated that the investigational antiplatelet compound met its primary...

2009-02-23 06:21:00

TOKYO and INDIANAPOLIS, Feb. 23 /PRNewswire-FirstCall/ -- Heart patients with acute coronary syndrome (ACS) undergoing an artery-opening procedure will soon have a new treatment option to help prevent heart attacks.

2009-02-20 13:21:00

Multi-Specialty Physician Panel Weighs in on Likely Positioning for Lilly/Daiichi's Prasugrel SCOTTSDALE, Ariz., Feb.

2009-02-11 23:01:00

-- Portola to Receive $75 Million Upfront Cash Payment, $500 Million in Potential Milestone Payments Plus Royalties on Future Sales -- SOUTH SAN FRANCISCO, Calif., Feb.

2009-02-03 17:08:00

TOKYO and INDIANAPOLIS, Feb. 3 /PRNewswire-FirstCall/ -- The U.S.

2008-12-31 07:14:00

TOKYO and INDIANAPOLIS, Dec. 31 /PRNewswire-FirstCall/ -- Daiichi Sankyo Company, Limited (TSE: 4568) and Eli Lilly and Company (NYSE: LLY) today confirmed that the U.S.

2008-11-13 09:00:37

Portola Pharmaceuticals, a biopharmaceutical company, has announced new clinical data that demonstrate PRT060128, the company's novel anti-platelet drug that directly and reversibly inhibits the P2Y12 ADP receptor, overcomes high platelet reactivity in patients who do not respond to clopidogrel.

Word of the Day
  • A young chicken: also used as a pet name for children.
The word 'chickabiddy' may come from 'chick' plus 'biddy', a name used in calling a hen or chicken.